MedTrace Logo

Contraceptive Efficacy Study of Ovaprene

NCT06127199 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 656

Last updated 2026-05-11

No results posted yet for this study

Summary

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

Conditions

  • Contraception

Interventions

DEVICE

Ovaprene

Non-hormonal intravaginal ring

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Daré Bioscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Christine Mauck, MD · Daré Bioscience, Inc.

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-19
Primary Completion
2027-04-30
Completion
2027-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06127199 on ClinicalTrials.gov